Form 4: Ingevity Director Acquires Shares

Ingevity Corp. director J. Kevin Willis acquired 397 shares of common stock through a deferred compensation plan.

Summary

• J. Kevin Willis, a director at Ingevity Corporation (NGVT), acquired 397 shares of common stock on July 1, 2026.
• The acquisition was made through vested deferred stock units (DSUs) granted in lieu of quarterly director fees.
• These DSUs were received under the company's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.
• The transaction price for the DSUs was $72.58 per share.
• Following this transaction, Mr. Willis beneficially owns 11,478 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction related to director compensation rather than a significant strategic or financial event.

Positives

• Director J. Kevin Willis demonstrates continued investment in the company through the acquisition of shares via deferred compensation.
• The acquisition of 397 shares indicates a commitment to the company's long-term performance.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of shares by a director, can be interpreted as a signal of confidence in the company's future prospects within the specialty chemicals and materials industry.

Stakeholder Impact

• Shareholders may view the director's acquisition of shares positively, as it can signal confidence in the company's value and future performance.

Next Steps

• The acquired DSUs will settle into an equal number of shares of the Company's Common Stock upon the reporting person's termination of board service.

Key Dates

Keywords

Ingevity Corp, NGVT, Form 4, Director, Deferred Stock Units, Common Stock, Insider Transaction, Securities Exchange Act